Natasha Giordano - Feb 22, 2022 Form 4 Insider Report for PLx Pharma Inc. (PLXPQ)

Role
Chief Executive Officer, Director
Signature
/s/ Natasha Giordano
Stock symbol
PLXPQ
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 07:13 PM
Previous filing
Nov 2, 2021
Next filing
Mar 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLXPQ Stock Option (right to buy) Award $0 +300K $0.00 300K Feb 22, 2022 Common Stock 300K $4.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended.
F2 These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.